Safety, Tolerability and Preliminary Efficacy of AZD5213 in Combination With Pregabalin in Subjects With PDN and Good Pain Reporting Ability

Clinical trial NCT01928381 · COMPLETED

Trial details

NCT number: NCT01928381
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetic Neuropathy, Painful; Diabetic Neuropathies

Start date: 2013-11-01
Primary completion: 2015-05-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.